Initiation of proton pump inhibitor (PPI) use is associated with an increased risk for asthma among children compared with nonuse, according to a study published online Feb. 8 in JAMA Pediatrics.
Yun-Han Wang, from the Karolinska Institutet in Stockholm, and colleagues examined the association between PPI use and risk for asthma in children in a nationwide cohort study. Data were included for 80,870 pairs of children and adolescents aged 17 years or younger matched by age and propensity scores.
The researchers found that the incidence rate of asthma was higher for those who initiated PPI use versus noninitiators (21.8 versus 14.0 events per 1,000 person-years), with a hazard ratio of 1.57. Across all age groups, there was a significantly increased risk for asthma, with the highest risk observed for infants and toddlers (hazard ratios, 1.83 for those agedRead:Rwanda to grow medical cannabis, strictly for export
“These findings suggest that asthma is one of several potential adverse events that should be considered when prescribing PPIs to children,” the authors write.
Two authors disclosed financial ties to the pharmaceutical industry.
Asthma, uncontrolled asthma associated with risk of A-fibRead:Help young athletes keep their competitive edge during pandemic
Abstract/Full Text (subscription or payment may be required)
Copyright © 2020 HealthDay. All rights reserved.
Read:Suicide rates increase after disasters strike, researcher finds
Child proton pump inhibitor use may increase asthma risk (2021, February 9)
retrieved 9 February 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.